Initial Immune Reactions to Intradermal Lipopolysaccharide in Healthy Subjects
Overview
This study characterizes the early immune response to intradermal lipopolysaccharide (LPS) in healthy individuals, highlighting the rapid activation of neutrophils and cytokine release. Prednisolone was found to modulate some inflammatory responses but did not significantly affect early neutrophil recruitment or cytokine levels.
Background
Understanding the early immune response to LPS is crucial for developing therapies targeting inflammatory conditions. The intradermal LPS model provides insights into TLR4-mediated inflammation, which is relevant in various inflammatory and autoimmune disorders. Previous studies have not adequately captured the initial kinetics of this response, necessitating further investigation.
Data Highlights
Time Point
Response
1 hour
Peak IL-8, neutrophil influx
3-6 hours
Peak IL-6, IL-1β
24 hours
Peak NET formation
Key Findings
Intradermal LPS injection triggers rapid skin perfusion and erythema within 1 hour.
IL-8 levels peak at 1 hour, while IL-6 and IL-1β peak at 3-6 hours post-injection.
Neutrophil influx and NET formation are observed as early as 1 hour, with peak NET formation at 24 hours.
NLRP3 inflammasome activation peaks at 3 hours, indicated by ASC and NLRP3 expression.
Oral prednisolone reduces vascular responses and intermediate monocyte infiltration but has limited effects on early cytokine levels and neutrophil responses.
Clinical Implications
Expand on how these findings could influence future therapeutic strategies beyond corticosteroids.
Conclusion
Reiterate the importance of early neutrophil responses in the context of developing new therapies.
by Thomas P. Buters, Digna T. de Bruin, Pieter W. Hameeteman, Wouter ten Voorde, Hendrika W. Grievink, Michelle Osse, Marieke L. de Kam, Jeffrey Damman, Thierry P. P. van den Bosch, Elsa Neubert, Robert Rissmann, Jacobus Burggraaf, Naomi Klarenbeek, Manon A. A. Jansen, Matthijs Moerland
